• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞动脉炎与高安动脉炎:同一硬币的两面?

Giant cell arteritis versus Takayasu's Arteritis: Two sides of the same coin?

作者信息

Mortensen Peter W, Raviskanthan Subahari, Chévez-Barrios Patricia, Lee Andrew G

机构信息

Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA.

Departments of Ophthalmology, Weill Cornell Medicine, New York, USA.

出版信息

Saudi J Ophthalmol. 2022 Apr 18;35(3):198-203. doi: 10.4103/SJOPT.SJOPT_152_21. eCollection 2021 Jul-Sep.

DOI:10.4103/SJOPT.SJOPT_152_21
PMID:35601856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9116096/
Abstract

There are multiple vasculitides which are distinguished based on multiple criteria, including size of affected vessels, distribution of vessels affected, histopathologic differences, genetic factors, and age at presentation. Takayasu's arteritis (TkA) and giant cell arteritis (GCA) are the two main medium to large vessel vasculitides. These vasculitides are associated with different racial predilections, vascular distributions, age groups, diagnostic criteria, and treatments. Nevertheless, the many shared histopathologic features, genetic factors, and overlap in presentation of these two diseases suggest that they may actually be variable presentations of the same disease process, i.e., large vessel vasculitis. This article will review the genetics, histopathology, disease mechanisms, and diagnostic criteria for both TkA and GCA. Overall, despite major advances our understanding of these two diseases, it is still debated whether these two large vessel vasculitides represent two distinct diseases processes or simply variations of the same disease.

摘要

有多种血管炎,可根据多种标准进行区分,包括受累血管的大小、受累血管的分布、组织病理学差异、遗传因素以及发病年龄。高安动脉炎(Takayasu's arteritis,TkA)和巨细胞动脉炎(giant cell arteritis,GCA)是两种主要的中到大血管血管炎。这些血管炎与不同的种族倾向、血管分布、年龄组、诊断标准和治疗方法相关。然而,这两种疾病许多共同的组织病理学特征、遗传因素以及临床表现的重叠表明,它们实际上可能是同一疾病过程的不同表现形式,即大血管血管炎。本文将综述TkA和GCA的遗传学、组织病理学、疾病机制及诊断标准。总体而言,尽管我们对这两种疾病的理解取得了重大进展,但这两种大血管血管炎是代表两种不同的疾病过程还是仅仅是同一疾病的不同变体仍存在争议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdc6/9116096/6a85e036c79d/SJO-35-198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdc6/9116096/6a85e036c79d/SJO-35-198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdc6/9116096/6a85e036c79d/SJO-35-198-g001.jpg

相似文献

1
Giant cell arteritis versus Takayasu's Arteritis: Two sides of the same coin?巨细胞动脉炎与高安动脉炎:同一硬币的两面?
Saudi J Ophthalmol. 2022 Apr 18;35(3):198-203. doi: 10.4103/SJOPT.SJOPT_152_21. eCollection 2021 Jul-Sep.
2
Imaging in Large Vessel Vasculitides.大血管血管炎的影像学检查
Rofo. 2019 Dec;191(12):1083-1090. doi: 10.1055/a-0896-2833. Epub 2019 May 16.
3
Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis.巨细胞(颞)动脉炎与高安动脉炎的临床鉴别
J Rheumatol. 1996 Jan;23(1):106-11.
4
[Eye involvement in large vesssel vasculitis (giant cell arteritis and Takayasu's arteritis)].[眼部受累于大血管血管炎(巨细胞动脉炎和高安动脉炎)]
Ophthalmologe. 2019 Sep;116(9):899-914. doi: 10.1007/s00347-019-00959-9.
5
Therapeutic update in large vessel vasculitides.大血管血管炎的治疗进展
Rev Clin Esp (Barc). 2013 Oct;213(7):338-46. doi: 10.1016/j.rce.2013.03.008. Epub 2013 May 15.
6
[Large-vessel vasculitides].[大血管血管炎]
Duodecim. 2011;127(15):1539-47.
7
Biologic treatment of large-vessel vasculitides.大血管血管炎的生物治疗。
Curr Opin Rheumatol. 2012 Jan;24(1):31-7. doi: 10.1097/BOR.0b013e32834dc392.
8
Large-vessel GCA or a late presentation of Takayasu's arteritis?大血管巨细胞动脉炎还是高安动脉炎的晚期表现?
BMJ Case Rep. 2012 May 30;2012:bcr0320125995. doi: 10.1136/bcr.03.2012.5995.
9
Cardiovascular Disease in Large Vessel Vasculitis: Risks, Controversies, and Management Strategies.大血管血管炎中的心血管疾病:风险、争议和管理策略。
Rheum Dis Clin North Am. 2023 Feb;49(1):81-96. doi: 10.1016/j.rdc.2022.08.004.
10
What is the best approach to diagnosing large-vessel vasculitis?诊断大血管血管炎的最佳方法是什么?
Best Pract Res Clin Rheumatol. 2005 Apr;19(2):223-42. doi: 10.1016/j.berh.2005.01.006.

本文引用的文献

1
Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event.巨细胞动脉炎诊断时的症状性主动脉炎:主动脉事件的一个预后因素。
Arthritis Res Ther. 2021 Jan 7;23(1):14. doi: 10.1186/s13075-020-02396-5.
2
Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu's arteritis patients.高安动脉炎患者急性期反应物、白细胞介素-6、肿瘤坏死因子-α与疾病活动度之间的关联
Arthritis Res Ther. 2020 Dec 10;22(1):285. doi: 10.1186/s13075-020-02365-y.
3
Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial.
托珠单抗治疗未经治疗的 Takayasu 动脉炎患者:TOCITAKA 法国前瞻性多中心开放标签试验。
Arthritis Res Ther. 2020 Sep 17;22(1):218. doi: 10.1186/s13075-020-02311-y.
4
Giant Cell Arteritis versus Takayasu Arteritis: An Update.巨细胞动脉炎与高安动脉炎:最新进展
Mediterr J Rheumatol. 2020 Jun 30;31(2):174-182. doi: 10.31138/mjr.31.2.174. eCollection 2020 Jun.
5
Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis - part I.血管炎最新进展:临床及组织病理学诊断概述与皮肤学线索——第一部分
An Bras Dermatol. 2020 May-Jun;95(3):355-371. doi: 10.1016/j.abd.2020.01.003. Epub 2020 Mar 26.
6
Endovascular biopsy in Takayasu arteritis.大动脉炎的血管内活检
Eur J Rheumatol. 2018 Dec 18;6(3):155-157. doi: 10.5152/eurjrheum.2018.18057. Print 2019 Jul.
7
Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.甲氨蝶呤治疗巨细胞动脉炎的真实世界疗效:一项病例对照研究。
J Rheumatol. 2019 May;46(5):501-508. doi: 10.3899/jrheum.180429. Epub 2019 Jan 15.
8
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).托珠单抗治疗难治性大动脉炎的疗效和安全性:来自日本一项随机、双盲、安慰剂对照、3 期临床试验(TAKT 研究)的结果。
Ann Rheum Dis. 2018 Mar;77(3):348-354. doi: 10.1136/annrheumdis-2017-211878. Epub 2017 Nov 30.
9
The genetics of Takayasu arteritis.大动脉炎的遗传学
Presse Med. 2017 Jul-Aug;46(7-8 Pt 2):e179-e187. doi: 10.1016/j.lpm.2016.11.031. Epub 2017 Jul 26.
10
Trial of Tocilizumab in Giant-Cell Arteritis.托珠单抗治疗巨细胞动脉炎的临床试验。
N Engl J Med. 2017 Jul 27;377(4):317-328. doi: 10.1056/NEJMoa1613849.